CASE REPORT article
Front. Oncol.
Sec. Radiation Oncology
Volume 15 - 2025 | doi: 10.3389/fonc.2025.1604056
Case report: malignant transformation of maxillary giant cell tumor of bone from EURACAN reference center
Provisionally accepted- 1Department of clinical and molecular medicine – “La Sapienza”, University of Rome, Rome, Italy
- 2Sarcomas and Rare Tumors Unit, Clinical Department and Oncological Research, Regina Elena National Cancer Institute (IRCCS), Rome, Lazio, Italy
- 3Department of Pathology, IRCCS Regina Elena National Cancer Institute, 00144, Rome, Italy
- 4Department of Radiological, Oncological and Pathological Sciences, Sapienza, University of Rome, Rome, Italy
- 5Radiation Oncology Unit, Clinical Department, CNAO National Center for Oncological Hadrontherapy, 27100, Pavia, Italy
- 6Radiology Department, IRCCS Regina Elena National Cancer Institute, 0014, Rome, Italy
- 7Rare Tumors and Melanoma Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Tumori Giovanni Paolo II, Bari, Italy
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Giant cell tumor of bone (GCTB) is a benign but locally aggressive neoplasm that can rarely undergo malignant transformation, with poor prognosis. The most frequent histotypes of sarcomatous transformation of GCTB are osteosarcoma, fibrosarcoma, or undifferentiated pleomorphic sarcoma and the treatment approach mirrors that of high-grade sarcomas. This case report describes the malignant transformation of a maxillary GCTB treated with standard systemic treatments for bone tumors and local treatment, resulting in a progression of disease until patient's death. Neverthless, a marked radiological and clinical response was achieved with local carbon ion therapy. This case highlights the diagnostic and therapeutic challenges of malignant transformation in GCTB, emphasizing the importance of a multidisciplinary approach at specialized centers and the potential role of local therapies in selected cases.
Keywords: Giant Cell Tumor of Bone, Sarcoma, malignant transformation, Hadrontherapy, case report
Received: 01 Apr 2025; Accepted: 24 Jun 2025.
Copyright: © 2025 RIVA, VARI, Onesti, Covello, Scuderi, Ceddia, Fiore, Anelli, Strippoli and Ferraresi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: SABRINA VARI, Sarcomas and Rare Tumors Unit, Clinical Department and Oncological Research, Regina Elena National Cancer Institute (IRCCS), Rome, 00144, Lazio, Italy
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.